Eventide Asset Management’s Coherus Oncology CHRS Stock Holding History

Eventide Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell
2017 Q3	$1.94M	Hold
2017 Q2	$2.08M	Hold
2017 Q1	$3.07M	Hold
2016 Q4	$4.08M	Hold
2016 Q3	$3.88M	Hold
2016 Q2	$2.45M	Hold
2016 Q1	$3.08M	Buy